Approach Major pharmaceutical and agriculture companies have, for decades, been reducing resources from the discovery of natural products; MicroMGx is in a position to deliver new value in this space through the integration of metabolomics, genome sequencing, and bioinformatics. Discovery MicroMGx stands on the precipice of delivering a high throughput means of discovery that is disruptive and orthogonal to the contemporary paradigms of natural product discovery. Our team was the first to publish the process of metabologenomics. Development Through the scaling of metabologenomics and bioinformatics, we can predict the structures and activities of thousands of novel natural products from our clients’ microbial strains.